SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-151714
Filing Date
2021-05-05
Accepted
2021-05-05 16:10:04
Documents
15
Period of Report
2021-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d186026d8k.htm   iXBRL 8-K 59900
2 EX-10.1 d186026dex101.htm EX-10.1 1251872
3 EX-99.1 d186026dex991.htm EX-99.1 20752
7 GRAPHIC g186026dsp01.jpg GRAPHIC 4079
  Complete submission text file 0001193125-21-151714.txt   1788206

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA jazz-20210505.xsd EX-101.SCH 3074
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20210505_lab.xml EX-101.LAB 18838
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20210505_pre.xml EX-101.PRE 11841
8 EXTRACTED XBRL INSTANCE DOCUMENT d186026d8k_htm.xml XML 3535
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 21893322
SIC: 2834 Pharmaceutical Preparations